Acupuncture for Chemotherapy-induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Official title:
The Efficacy and Safety of Acupuncture for Alleviating Chemotherapy-induced Peripheral Neuropathy in Colorectal Cancer Patients: a Pilot Single-blinded, Randomized Sham-controlled Trial

Status Completed

Clinical Trial Summary

In this study, a 24-week, single blinded, randomized controlled clinical trial will be conducted to examine the efficacy and safety of acupuncture for Chemotherapy Induced Peripheral Neuropathy (CIPN) in colorectal cancer patients in Hong Kong.

Clinical Trial Description

This is a pilot single-blind, randomized, sham-controlled trial. 84 colorectal cancer patients will be randomly assigned to acupuncture group or control group. The duration of the treatment will be 12 weeks with 1 session per week and the follow-up period will be 12 weeks. ;

Study Design

Related Conditions & MeSH terms

Chemotherapy Induced Peripheral Neuropathy
Peripheral Nervous System Diseases

Clinical Trial Details

NCT number	NCT03582423
Study type	Interventional
Source	Hong Kong Baptist University
Contact
Status	Completed
Phase	N/A
Start date	October 22, 2018
Completion date	September 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03872141` - Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients
Completed	`NCT02773329` - Using Game-based Exercise to Improve Balance in Cancer Patients	Phase 2
Completed	`NCT03786055` - Somatic Yoga and Meditation for Cancer Survivors With Pain From Neuropathy	N/A
Completed	`NCT03344328` - Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders.
Not yet recruiting	`NCT05680870` - The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients	Phase 3